Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.
Emergency Lung Transplantation after COVID-19: Immunopathological Insights on Two Affected Patients.
复制标题
DOI:
10.3390/cells10030611
复制
发表时间:
2021-03-10
期刊:
影响因子:
6
通讯作者:
Ferrero S
中科院分区:
文献类型:
--
作者:
Croci GA;Vaira V;Trabattoni D;Biasin M;Valenti L;Baselli G;Barberis M;Guerini Rocco E;Gregato G;Scandroglio M;Fominskiy E;Palleschi A;Rosso L;Nosotti M;Clerici M;Ferrero S
We herein characterize the immunopathological features of two Italian COVID-19 patients who underwent bilateral lung transplantation (bLTx). Removed lungs underwent histopathological evaluation. Gene expression profiling (GEP) for immune-related signatures was performed on lung specimens and SARS-CoV-2-stimulated peripheral blood mononuclear cells (PBMCs). Cytokine levels were measured on lungs, bronchoalveolar lavage fluids and in culture supernatants. Pathological assessment showed extensive lung damage with the pattern of proliferative to fibrotic phases, with diffuse alveolar damage mimicking usual interstitial pneumonia (UIP). Lungs’ GEP revealed overexpression of pathogen recognition receptors, effector cytokines and chemokines, immune activation receptors and of the inflammasome components. Multiplex cytokine analysis confirmed a proinflammatory state, with high levels of monocyte/macrophage chemotactic and activating factors and of IL-6 and TNF-α. A similar profile was observed in SARS-CoV-2-stimulated PBMCs collected 7 days after transplant. The pattern of tissue damage observed in the lungs suggests that this may represent the output of protracted disease, resembling a diffuse UIP-like picture. The molecular immune profiling supports the paradigm of a persistent proinflammatory state and sustained humoral immunity, conditions that are maintained despite the iatrogenic immunosuppression.
登录
查看更多内容
影响因子:
17.1
作者:
Bharat A;Querrey M;Markov NS;Kim S;Kurihara C;Garza-Castillon R;Manerikar A;Shilatifard A;Tomic R;Politanska Y;Abdala-Valencia H;Yeldandi AV;Lomasney JW;Misharin AV;Budinger GRS
通讯作者:
Budinger GRS
影响因子:
158.5
作者:
Ackermann, Maximilian;Verleden, Stijn E.;Jonigk, Danny
通讯作者:
Jonigk, Danny
影响因子:
3.4
作者:
Guerini-Rocco, Elena;Taormina, Sergio Vincenzo;Barberis, Massimo
通讯作者:
Barberis, Massimo
影响因子:
3.5
作者:
Pernazza, Angelina;Mancini, Massimiliano;D'Amati, Giulia
通讯作者:
D'Amati, Giulia
DOI:
10.1001/jama.2020.6775
发表时间:
2020-01-01
期刊:
JAMA, Journal of the American Medical Association
影响因子:
--
作者:
Richardson, Safiya;Hirsch, Jamie S.;,
通讯作者:
,